Your browser doesn't support javascript.
The SARS-CoV-2 viral load in COVID-19 patients is lower on face mask filters than on nasopharyngeal swabs.
Smolinska, Agnieszka; Jessop, David S; Pappan, Kirk L; De Saedeleer, Alexandra; Kang, Amerjit; Martin, Alexandra L; Allsworth, Max; Tyson, Charlotte; Bos, Martine P; Clancy, Matt; Morel, Mike; Cooke, Tony; Dymond, Tom; Harris, Claire; Galloway, Jacqui; Bresser, Paul; Dijkstra, Nynke; Jagesar, Viresh; Savelkoul, Paul H M; Beuken, Erik V H; Nix, Wesley H V; Louis, Renaud; Delvaux, Muriel; Calmes, Doriane; Ernst, Benoit; Pollini, Simona; Peired, Anna; Guiot, Julien; Tomassetti, Sara; Budding, Andries E; McCaughan, Frank; Marciniak, Stefan J; van der Schee, Marc P.
  • Smolinska A; Owlstone Medical Ltd., Cambridge, Cambridgeshire, UK.
  • Jessop DS; Department of Pharmacology and Toxicology, Maastricht University, Maastricht, The Netherlands.
  • Pappan KL; Owlstone Medical Ltd., Cambridge, Cambridgeshire, UK.
  • De Saedeleer A; Owlstone Medical Ltd., Cambridge, Cambridgeshire, UK.
  • Kang A; Owlstone Medical Ltd., Cambridge, Cambridgeshire, UK.
  • Martin AL; Owlstone Medical Ltd., Cambridge, Cambridgeshire, UK.
  • Allsworth M; Owlstone Medical Ltd., Cambridge, Cambridgeshire, UK.
  • Tyson C; Owlstone Medical Ltd., Cambridge, Cambridgeshire, UK.
  • Bos MP; Owlstone Medical Ltd., Cambridge, Cambridgeshire, UK.
  • Clancy M; inBiome B.V., Amsterdam, The Netherlands.
  • Morel M; inBiome B.V., Amsterdam, The Netherlands.
  • Cooke T; Cambridge Clinical Laboratories Ltd., Cambridge, Cambridgeshire, UK.
  • Dymond T; Cambridge Clinical Laboratories Ltd., Cambridge, Cambridgeshire, UK.
  • Harris C; Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK.
  • Galloway J; Department of Medicine, Addenbrooke's Hospital, Cambridge, UK.
  • Bresser P; University of Cambridge, Cambridge, UK.
  • Dijkstra N; Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK.
  • Jagesar V; Pulmonology, OLVG, Amsterdam, The Netherlands.
  • Savelkoul PHM; Pulmonology, OLVG, Amsterdam, The Netherlands.
  • Beuken EVH; Pulmonology, OLVG, Amsterdam, The Netherlands.
  • Nix WHV; Department of Medical Microbiology, Maastricht University Medical Center, Care and Public Health Research Institute (Caphri), Maastricht, The Netherlands.
  • Louis R; Department of Medical Microbiology, Maastricht University Medical Center, Care and Public Health Research Institute (Caphri), Maastricht, The Netherlands.
  • Delvaux M; Department of Medical Microbiology, Maastricht University Medical Center, Care and Public Health Research Institute (Caphri), Maastricht, The Netherlands.
  • Calmes D; Repiratory Department, CHU Liège, Liège, Belgium.
  • Ernst B; Repiratory Department, CHU Liège, Liège, Belgium.
  • Pollini S; Repiratory Department, CHU Liège, Liège, Belgium.
  • Peired A; Repiratory Department, CHU Liège, Liège, Belgium.
  • Guiot J; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Tomassetti S; Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy.
  • Budding AE; Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
  • McCaughan F; Repiratory Department, CHU Liège, Liège, Belgium.
  • Marciniak SJ; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • van der Schee MP; Interventional Pulmonology Unit, Careggi University Hospital, Florence, Italy.
Sci Rep ; 11(1): 13476, 2021 06 29.
Article in English | MEDLINE | ID: covidwho-1287817
ABSTRACT
Face masks and personal respirators are used to curb the transmission of SARS-CoV-2 in respiratory droplets; filters embedded in some personal protective equipment could be used as a non-invasive sample source for applications, including at-home testing, but information is needed about whether filters are suited to capture viral particles for SARS-CoV-2 detection. In this study, we generated inactivated virus-laden aerosols of 0.3-2 microns in diameter (0.9 µm mean diameter by mass) and dispersed the aerosolized viral particles onto electrostatic face mask filters. The limit of detection for inactivated coronaviruses SARS-CoV-2 and HCoV-NL63 extracted from filters was between 10 to 100 copies/filter for both viruses. Testing for SARS-CoV-2, using face mask filters and nasopharyngeal swabs collected from hospitalized COVID-19-patients, showed that filter samples offered reduced sensitivity (8.5% compared to nasopharyngeal swabs). The low concordance of SARS-CoV-2 detection between filters and nasopharyngeal swabs indicated that number of viral particles collected on the face mask filter was below the limit of detection for all patients but those with the highest viral loads. This indicated face masks are unsuitable to replace diagnostic nasopharyngeal swabs in COVID-19 diagnosis. The ability to detect nucleic acids on face mask filters may, however, find other uses worth future investigation.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Nasopharynx / SARS-CoV-2 / COVID-19 / Masks Type of study: Diagnostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged / Young adult Language: English Journal: Sci Rep Year: 2021 Document Type: Article Affiliation country: S41598-021-92665-3

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Nasopharynx / SARS-CoV-2 / COVID-19 / Masks Type of study: Diagnostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged / Young adult Language: English Journal: Sci Rep Year: 2021 Document Type: Article Affiliation country: S41598-021-92665-3